- Home
- LSPD vs RCKT Comparison
LSPD vs RCKT Comparison
Compare LSPD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- RCKT
- Stock Information
- Founded
- LSPD 2005
- RCKT 1999
- Country
- LSPD Canada
- RCKT United States
- Employees
- LSPD N/A
- RCKT N/A
- Industry
- LSPD
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- LSPD
- RCKT Health Care
- Exchange
- LSPD Nasdaq
- RCKT Nasdaq
- Market Cap
- LSPD 1.7B
- RCKT 328.6M
- IPO Year
- LSPD 2020
- RCKT N/A
- Fundamental
- Price
- LSPD $12.67
- RCKT $3.14
- Analyst Decision
- LSPD Buy
- RCKT Buy
- Analyst Count
- LSPD 13
- RCKT 13
- Target Price
- LSPD $14.19
- RCKT $12.96
- AVG Volume (30 Days)
- LSPD 458.6K
- RCKT 5.7M
- Earning Date
- LSPD 11-06-2025
- RCKT 11-06-2025
- Dividend Yield
- LSPD N/A
- RCKT N/A
- EPS Growth
- LSPD N/A
- RCKT N/A
- EPS
- LSPD N/A
- RCKT N/A
- Revenue
- LSPD $1,115,677,000.00
- RCKT N/A
- Revenue This Year
- LSPD $14.22
- RCKT N/A
- Revenue Next Year
- LSPD $12.03
- RCKT $108.43
- P/E Ratio
- LSPD N/A
- RCKT N/A
- Revenue Growth
- LSPD 15.46
- RCKT N/A
- 52 Week Low
- LSPD $7.34
- RCKT $2.19
- 52 Week High
- LSPD $18.96
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- LSPD 58.86
- RCKT 46.59
- Support Level
- LSPD $11.66
- RCKT $3.09
- Resistance Level
- LSPD $13.06
- RCKT $3.29
- Average True Range (ATR)
- LSPD 0.33
- RCKT 0.15
- MACD
- LSPD 0.08
- RCKT -0.03
- Stochastic Oscillator
- LSPD 70.71
- RCKT 27.10
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.